Navigation Links
I.V. Clinical Integration Helps Deliver Safety, Efficiency And Financial Benefits; Hospira Shares Snapshot Of Results, Process

LAKE FOREST, Ill., May 24, 2012 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today released a snapshot of the positive impact of I.V. clinical integration of infusion pumps and electronic health records (EHRs) in honor of Healthcare Technology Management Week, which recognizes the important work of healthcare technology professionals.



"The I.V. clinical integration of infusion pumps with electronic health record systems has been shown to decrease the time it takes for nurses to start a new infusion by at least 27 percent,"[1] said Richard Nevin, vice president, Medication Management Systems, U.S., Hospira. "Using I.V. clinical integration to link a smart infusion pump with EHRs helps deliver the trifecta for hospitals: safety, efficiency and financial benefits."

The following multimedia assets provide additional information about how I.V. clinical integration can enhance patient safety, clinician workflow and cost prevention efforts:

  • Why I.V. Clinical Integration of Infusion Pumps is So Smart: This infographic illustrates the functionality and benefits of I.V. clinical integration with Hospira MedNet™ safety software, including visuals that reflect the number of steps that can be removed from the medication delivery process.
  • Symbiq™ Infusion Pump Overview Video: A quick look at Hospira's newly enhanced Symbiq device -- recently given the first general infusion pump clearance from the U.S. Food and Drug Administration (FDA) under the new 510(k) guidelines -- and the role it plays in I.V. clinical integration.
  • An online hub of visual resources, case studies and news about I.V. clinical integration.

Using I.V. clinical integration to integrate medication management technologies with EHRs enables seamless, near real-time sharing of patient and infusion information between the hospital's clinical information systems, medication pumps and other devices. Intravenous or I.V. medication administration is crucial to the health of patients, as 90 percent of hospital patients receive an infusion as part of their treatments, and 56 percent of all medication errors are associated with I.V. medications.[2],[3] Improving the process through clinical integration can help clinicians positively impact their patients' overall health and safety.

About Hospira

Hospira, Inc. is the world's leading provider of injectable drugs and infusion technologies. Through its broad, integrated portfolio, Hospira is uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs. The company is headquartered in Lake Forest, Ill., and has approximately 15,000 employees. Learn more at

[1] WellSpan Health. "WellSpan's collaborative efforts lead to Way-Paver," June 10, 2011,, Accessed May 17, 2012.

[2] Hanchett, M. Visualizing the IV fluid path as an emerging concept in infection control. Infection Control Today. February 2004.

[3] Ross LM, Wallace J, Paton JY. Medication errors in a pediatric teaching hospital in the UK: five years operational experience. Arch Dis Child. 2000; 83(6);492-497


SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
(Date:6/24/2016)... , June 24, 2016   Bay Area ... Network,s Dean Center for Tick Borne Illness ... and Rehabilitation, MIT Hacking Medicine, University of California, ... today announced the five finalists of Lyme ... disease.  More than 100 scientists, clinicians, researchers, entrepreneurs, ...
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
(Date:6/24/2016)... 2016 Research and Markets has announced ... Diagnostic Tests" report to their offering. ... The World Market for Companion Diagnostics covers ... Market analysis in the report includes the following: ... Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... payment industry today announced its strategic partnership with Connance, a healthcare industry ... The two companies’ proven, proprietary technology combine to provide health systems, hospitals ...
(Date:6/26/2016)... California (PRWEB) , ... June 26, 2016 , ... Pixel ... Cut Pro X. , "Film editors can give their videos a whole new perspective ... Christina Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... City, Oklahoma (PRWEB) , ... June 25, 2016 ... ... helping both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic ... the Oklahoma City area —Johnson is one of the first doctors to perform ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
Breaking Medicine News(10 mins):